KARINA ARRELUCEA: Open Payments
NPI 1588303895 · RUTHERFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,801 in 56 payments from 18 companies in 2025. Trend: 2023 $1,850 · 2024 $1,303 · 2025 $1,801
Food & beverage: $1,801
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 9 | $529 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $169 |
| Lilly USA, LLC | 5 | $166 |
| Novo Nordisk Inc | 7 | $132 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Dexcom, Inc. | 1 | $122 |
| PFIZER INC. | 6 | $102 |
| ViiV Healthcare Company | 3 | $70 |
| Scilex Pharmaceuticals Inc. | 4 | $69 |
| Gilead Sciences, Inc. | 3 | $64 |
Products named: RELTONE 200 MG, XIFAXAN, MOUNJARO, Wegovy, Symbravo, Dexcom G6 Transmitter, NURTEC ODT, ZTLido.
Industry payments across NJ — which companies pay providers there.
